NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-099073 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
900,000
Total Value
$9,090,868.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Ordinary Shares | โ | Mar 5, 2026 | Exercise/Conversion | 104,467 | โ | โ | 173,769 | Indirect | See footnote | View Details | |
Director | Ordinary Shares | โ | Mar 5, 2026 | Sale | 104,467 | $30.30 | $3,165,350.10 | 69,302 | Indirect | See footnote | View Details | |
Director | Ordinary Shares | โ | Mar 6, 2026 | Exercise/Conversion | 94,124 | โ | โ | 163,426 | Indirect | See footnote | View Details | |
Director | Ordinary Shares | โ | Mar 6, 2026 | Sale | 94,124 | $30.32 | $2,853,839.68 | 69,302 | Indirect | See footnote | View Details | |
Director | Ordinary Shares | โ | Mar 9, 2026 | Exercise/Conversion | 101,409 | โ | โ | 170,711 | Indirect | See footnote | View Details | |
Director | Ordinary Shares | โ | Mar 9, 2026 | Sale | 101,409 | $30.29 | $3,071,678.61 | 69,302 | Indirect | See footnote | View Details | |
Director | Option (right to buy) | Derivative | Mar 5, 2026 | Exercise/Conversion | 104,467 | $0.00 | $0.00 | 715,762 | Indirect | See footnote | View Details | |
Director | Option (right to buy) | Derivative | Mar 6, 2026 | Exercise/Conversion | 94,124 | $0.00 | $0.00 | 621,638 | Indirect | See footnote | View Details | |
Director | Option (right to buy) | Derivative | Mar 9, 2026 | Exercise/Conversion | 101,409 | $0.00 | $0.00 | 520,229 | Indirect | See footnote | View Details |